$XXII “Lion Stock Alerts” Promoter Rank: 22/24 22nd Century Group, Inc. Newsletter 7:32:46 AM April 26, 2021

on April 26, 2021 Newsletters and Tags: , , , , , , , , , , with 0 comments

Overall Perfomance for "Lion Stock Alerts"

The following three charts can be used by potential investors to gauge the performance of "Lion Stock Alerts":

10%

1 out of 10 campaigns closed down on first day

40%

4 out of 10 campaigns closed up on first day

50%

5 out of 10 campaigns had no net effect

XXII Promotional Newsletter

The following is a newsletter released by "Lion Stock Alerts" promoting 22nd Century Group, Inc.

Caution

The following newsletter has not been verified for accuracy or completeness.

LionStockAlerts

Don't Want Anymore Emails

Hello

New Alert 22nd Century Group, Inc. NYSE XXII

Last week, there was a huge announcement that rocked an entire industry.

As Bloomberg reported on April 19th Tobacco Stocks Drop as U.S. May Curb Nicotine in Cigarettes

According to the American Lung Association

While overall cigarette use declined by 26% over the past decade, 91% of that decline was due to non-menthol cigarettes.

Sadly, smoking is the number one preventable cause of death in the U.S., killing over 480,000 people per year.

Despite this, the popularity of these products has been growing

In 2020, disposable e-cigarette use skyrocketed by 1,000% among high school e-cigarette users from 2.4% to 26.5% and 400% among middle school e-cigarette users from 3% to 15.2%.

Furthermore

More than 23.6% of high school students in the U.S. use at least one tobacco product, including e-cigarettes, according to the 2020 National Youth Tobacco Survey

Our new alert is an innovator in this space that could benefit from the growth potential of this industry shift.

XXII is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hempcannabis plants through genetic engineering, gene-editing, and modern plant breeding.

The companys primary mission in tobacco is to reduce the harm caused by smoking through the Companys proprietary reduced nicotine content tobacco cigarettes containing 95% less nicotine than conventional cigarettes.

In addition, the companys primary mission in hempcannabis is to develop and commercialize proprietary hempcannabis plants with valuable cannabinoid profiles and desirable agronomic traits.

As the company further explained in last weeks press release from April 20

22nd Centurys reduced nicotine content RNC cigarettes, VLN King and VLN Menthol King, contain levels of nicotine content that are minimally or non-addictive, unlike conventional cigarettes that are designed to create and sustain addiction to nicotine.

Made from proprietary tobacco engineered to contain 95% less nicotine than conventional cigarette tobacco, 22nd Centurys RNC cigarettes are the only combustible tobacco products able to meet the nicotine levels proposed in the FDAs ANPRM for a tobacco product standard reduce the nicotine content of all combustible cigarettes.

As the company further explained in its March Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020

22nd Century has a tremendous global commercial opportunity in the more than $800 billion markets across the tobacco and hempcannabis industry.
Securing Modified Risk Tobacco Product MRTP authorization for VLN remains 22nd Centurys number one priority. The Company is highly confident that the FDA is in the final stages of the review process related to its application.
22nd Century is fully prepared and eager to launch VLN King and VLN Menthol King within 90 days of receiving MRTP designation. MRTP designation is a catalyst for the VLN brand and tobacco franchise via partnerships and licensing agreements in the U.S. and internationally.

In addition, earlier this year the company announced

22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of HempCannabis Plants with Commercially Valuable Traits

As the company furthered explained in this press release

it has developed and launched a new, cutting-edge technology platform that will enable the Company and its strategic partners to quickly identify and incorporate commercially valuable traits of hempcannabis plants to create new, stable hempcannabis lines. The platform incorporates a suite of proprietary molecular tools and a large library of genomic markers and gene-trait correlations. The platform was developed in collaboration with researchers at KeyGene, a global leader in plant research involving high-value genetic traits and increased crop yields.

Here are the companys comments from this press release

This is a major breakthrough. Quickly and easily identifying the genes responsible for specific traits in a plant is a powerful tool for 22nd Century Group and the hempcannabis industry as a whole, said James A. Mish, chief executive officer of 22nd Century Group. That is why we are even now beginning discussions to license this platform to strategic partners to help them improve their plant breeding techniques and to optimize their hempcannabis cultivars. We continue to make great advancements through our partnership with KeyGene, and this newly developed molecular breeding platform has the potential to result in exponential growth for the Companys revenues and create new value opportunities for our stakeholders, including shareholders.

Furthermore, in March, the company announced

22nd Century Group Secures Exclusive Agreement with CannaMetrix to Accelerate Commercialization of New, Disruptive HempCannabis Plant Lines and Intellectual Property

Here are the companys comments from this press release

22nd Century is extremely excited to add CannaMetrix into our secured network of value chain partners to increase the speed at which we develop and offer disruptive plant lines and intellectual property for the hempcannabis industry. For example, a plant line that would typically take ten years or longer to develop can now be achieved in two years, said James A. Mish, chief executive officer of 22nd Century Group. As we monetize our current IP portfolio starting in 2021, our upstream hempcannabis partnerships will enable us to rapidly offer additional disruptive, commercially valuable plant lines at large scale and increased, stable yields to very attractive hempcannabis end-use markets. We are excited and absolutely confident in the future innovation and value creation that will stem from these coordinated strategic partnerships.

In just the month of April, the company has announced multiple developments that could position it for increased growth.

Multiple Former FDA Commissioners Voice Support for Reduced Nicotine Mandate Proposed Legislation Would Be Game-Changing for 22nd Century
22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine Products Committee
22nd Century Stands Fully Prepared to Enable New Zealand Proposal to Advance Nationwide Smoke-Free Action Plan

In addition, XXII announced multiple breaking developments last week

22nd Century Fully Prepared to Deliver the Solution as Biden Administration Considers Requirement to Lower Nicotine Level for All Cigarettes Sold in U.S.
22nd Century Group Issues Annual Letter to Shareholders
22nd Century Group to Host Webcast to Discuss First Quarter 2021 Results

XXII could present increased growth potential.

Make sure to do your own due diligence.

Sources , , , , , , , , , , , , ,

Happy Trading

LionStockAlerts

Note We encourage all traders and investors to develop personal trading rules that you can follow and that work for you. Always protect your downside and note that we alert extremely volatile short-term opportunities. Before investing in securities, you should always consult with your financial, tax and legal advisor and never invest money you cannot afford to lose.

--------------------------

DISCLAIMER

You should read and understand this disclaimer in its entirety before joining the website or emailblog list of LionStockAlerts.com the Publisher. The information collectively the Advertisement disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, andor losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply.

The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission the SEC at www.sec.gov the Financial Industry Regulatory Authority the FINRA at www.FINRA.org, and relevant State Securities Administrator website and the OTC Markets website at www.otcmarkets.com. The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.govconsumercyberfr.htm, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.

The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial andor legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.

Owners and operators of the Publisher have been compensated twenty two thousand five hundred dollars by bank wire transfer on 42121 for the distribution of this advertisement about XXII dated 42621. Prior to this period, at the time of publication, we disclosed our compensation for the distribution of advertisements about XXII. The Publisher and its owners and operators hold no stocks or bonds in companies discussed in the Advertisement. Owners and operators of the Publisher own several newsletters, therefore you may receive multiple publications and emails featuring companies at different or the same time.

You are receiving this reportrelease because you subscribed to receive it at our website or through a third-party site. All our newsletters include an unsubscribe link, and you can remove yourself at any time from our newsletters by clicking on that unsubscribe link. You can also contact us at infoLionStockAlerts.com to change your information at any time. By your subscription to our profiles, the viewing of this profile andor use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link

www.LionStockAlerts.comDisclaimer and www.LionStockAlerts.comPrivacy-Policy

By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of 1 a client company, 2 the party issuing or preparing the information for the company, or 3 other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated reportrelease or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.

Our records indicate that . requested and confirmed to be added to LionStockAlerts.com on July 23, 2019.

6020 Bent Pine Drive
Orlando FL 32828
USA